Synthesis and Structure-Activity Relationship of Furoquinolinediones As Inhibitors of Tyrosyl-DNA Phosphodiesterase 2 (TDP2).

Le-Mao Yu,Zhu Hu,Yu Chen,Azhar Ravji,Sophia Lopez,Caroline B. Plescia,Qian Yu,Hui Yang,Monica Abdelmalak,Sourav Saha,Keli Agama,Evgeny Kiselev,Christophe Marchand,Yves Pommier,Lin-Kun An
DOI: https://doi.org/10.1016/j.ejmech.2018.04.024
IF: 7.088
2018-01-01
European Journal of Medicinal Chemistry
Abstract:Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a recently discovered enzyme specifically repairing topoisomerase II (TOP2)-mediated DNA damage. It has been shown that inhibition of TDP2 synergize with TOP2 inhibitors. Herein, we report the discovery of the furoquinolinedione chemotype as a suitable skeleton for the development of selective TDP2 inhibitors. Compound 1 was identified as a TDP2 inhibitor as a result of screening our in-house compound library for compounds selective for TDP2 vs. TDP1. Further SAR studies provide several selective TDP2 inhibitors at low-micromolar range. The most potent compound 74 shows inhibitory activity with IC50 of 1.9 and 2.1 μM against recombinant TDP2 and TDP2 in whole cell extracts (WCE), respectively.
What problem does this paper attempt to address?